|
88
|
269
|
6npvA |
C-abl kinase domain with the activator(cmpd51), n-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1h-pyrazol-3-yl)isonicotinamide |
|
86
|
269
|
6npuA |
C-abl kinase domain with the activator(cmpd29), n-(1-(3,4-dichlorophenyl)-4,5-dihydro-1h-pyrazol-3-yl)acetamide |
|
26
|
87
|
5yrnA |
Structure of rip2 card domain |
|
89
|
271
|
6n9pA |
Discovery of affinity-based probes for btk occupancy assay |
|
79
|
268
|
6nfiA |
Btk in complex with inhibitor n-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide |
|
90
|
271
|
6nfhA |
Btk in complex with inhibitor 8-(2,3-dihydro-1h-inden-5-yl)-2-({4-[(2s)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione |
|
77
|
262
|
6mnyA |
Crystal structure of mouse btk kinase domain in complex with compound 9a |
|
84
|
275
|
6i8zA |
Crystal structure of ptk2 in complex with bi-4464. |
|
13
|
74
|
6c4sA |
Human csrc sh3 domain in complex with choline kinase fragment 60-69 |
|
141
|
457
|
6gfjA |
Structure of rip2 card domain fused to crystallisable mbp tag |
|
77
|
277
|
6ateA |
Src kinase bound to covalent inhibitor |
|
113
|
372
|
6cb0A |
Crystal structure of the fak ferm domain |
|
89
|
285
|
6ny4A |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor |
|
94
|
263
|
6hrpA |
Crystal structure of btk kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one |
|
92
|
268
|
6o8iA |
Btk in complex with inhibitor |
|
93
|
290
|
6n7aA |
Structure of the human jak1 kinase domain with compound 39 |
|
93
|
289
|
6n77A |
Structure of the human jak1 kinase domain with compound 15 |
|
15
|
63
|
6nmwA |
Crystal structure of the human lyn sh3 domain |
|
87
|
289
|
6n79A |
Structure of the human jak1 kinase domain with compound 20 |
|
93
|
290
|
6n7dA |
Structure of the human jak1 kinase domain with compound 54 |
|
92
|
290
|
6n7cA |
Structure of the human jak1 kinase domain with compound 56 |
|
89
|
289
|
6n78A |
Structure of the human jak1 kinase domain with compound 21 |
|
91
|
290
|
6n7bA |
Structure of the human jak1 kinase domain with compound 38 |
|
83
|
272
|
6gcwA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
84
|
274
|
6gcxA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
91
|
263
|
6hrtA |
Crystal structure of btk kinase domain complexed with 12-(6-tert-butyl-8-fluoro-1-oxo-phthalazin-2-yl)-9-hydroxy-6-methyl-4-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-azatricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,11,13-pentaen-5-one |
|
86
|
272
|
6g3cA |
Crystal structure of jak2-v617f pseudokinase domain in complex with compound 2 |
|
90
|
290
|
6gghA |
Human jak1 kinase domain in complex with inhibitor |
|
88
|
272
|
6gcrA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
68
|
259
|
6dflA |
Waap in complex with acyl carrier protein |
|
75
|
273
|
6d2iA |
Jak2 pseudokinase v617f in complex with at9283 |
|
84
|
274
|
3tudA |
Crystal structure of syk kinase domain with n-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide |
|
81
|
276
|
3tucA |
Crystal structure of syk kinase domain with 1-benzyl-n-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
79
|
276
|
3uqfA |
C-src kinase domain in complex with bki rm-1-89 |
|
84
|
272
|
3tubA |
Crystal structure of syk kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1r,2s)-2-phenylcyclopropyl)urea |
|
85
|
277
|
3svvA |
Crystal structure of t338c c-src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9 |
|
21
|
114
|
3s9kA |
Crystal structure of the itk sh2 domain. |
|
16
|
77
|
6edfA |
Fragment of a tyrosine-protein kinase |
|
91
|
290
|
6aahA |
Crystal structure of jak1 in complex with peficitinib |
|
91
|
291
|
6aamA |
Crystal structure of tyk2 in complex with peficitinib |
|
84
|
284
|
6aakA |
Crystal structure of jak3 in complex with peficitinib |
|
91
|
288
|
6aajA |
Crystal structure of jak2 in complex with peficitinib |
|
67
|
263
|
5xyzA |
The structure of human btk kinase domain in complex with a covalent inhibitor |
|
80
|
265
|
5xy1A |
Crystal structure of lyn kinase domain in complex with n-(1h-indazol-6-yl)-8-(piperidin-4-yloxy)-6-propylquinazolin-2-amine |
|
89
|
289
|
5ng3B |
Structure of inactive kinase rip2k(k47r) |
|
89
|
290
|
5ng3A |
Structure of inactive kinase rip2k(k47r) |
|
84
|
294
|
5ng2A |
Structure of rip2k(d146n) with bound staurosporine |
|
75
|
276
|
5swhA |
C-src v281c kinase domain in complex with rao-iv-151 |
|
19
|
90
|
5mtnA |
Monobody mb(lck_1) bound to lck-sh2 |
|
28
|
109
|
5mtjA |
Yes1-sh2 in complex with monobody mb(yes_1) |
